DexCom
DXCM
974 hedge funds and large institutions have $47.5B invested in DexCom in 2023 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 326 increasing their positions, 358 reducing their positions, and 114 closing their positions.
71% more first-time investments, than exits
New positions opened: 195 | Existing positions closed: 114
47% more funds holding in top 10
Funds holding in top 10: 17 → 25 (+8)
38% more capital invested
Capital invested by funds: $34.4B → $47.5B (+$13.2B)
8% more funds holding
Funds holding: 903 → 974 (+71)
4.32% more ownership
Funds ownership: 94.93% → 99.24% (+4.3%)
9% less repeat investments, than reductions
Existing positions increased: 326 | Existing positions reduced: 358
22% less call options, than puts
Call options by funds: $824M | Put options by funds: $1.05B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$590M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$537M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$375M |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
+$309M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$275M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$400M |
| 2 |
ClearBridge Investments
New York
|
-$329M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$302M |
| 4 |
Millennium Management
New York
|
-$179M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$132M |
DXCM Hedge Fund Activity: Q4 2023 in Review
974 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2023, worth a combined $47.5B — up 38% from $34.4B a quarter earlier.
Buyers outnumbered sellers: 195 funds opened new DXCM positions and 114 closed out — a net gain of 81 holders — while 326 added to existing stakes and 358 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $590M. The largest seller was Jennison Associates, cutting an estimated $400M.
- 974 institutional investors held DexCom (DXCM) as of Q4 2023, up from 903 in Q3 2023.
- Funds reported $47.5B of DexCom stock for Q4 2023, up 38% quarter-over-quarter.
- 195 funds opened new DexCom positions in Q4 2023 and 114 closed out, a net change of +81 holders.
- The largest DexCom buyer in Q4 2023 was Morgan Stanley, an estimated $590M added.
- The largest DexCom seller in Q4 2023 was Jennison Associates, an estimated $400M sold.
Based on aggregated 13F filings for Q4 2023.